IMPORTANT NOTE. We strongly recommend that you consult your doctor for proper advice before using any medications, including vitamins, supplements, herbals and products for the skin.
Brand Name, Dosage Format and Strength
Kastair EZTab 5 mg TABLET
Therapeutic Category
Respiratory System
Sub Therapeutic
Antiasthmatic and COPD Preparations, Cough and Cold Preparations
Class
Corticosteroid, Anticholinergic, Beta2-Agonist, Leukotriene Inhibitor, Beta2-Agonist, Beta2-Agonist, Expectorant, Antiasthma-Beta2- Agonist, Mucolytic, Beta2-Agonist, Mucolytic, Antitussive, Nasal Decongestant, Analgesic-Antipyretic, Antitussive, Nasal Decongestant, Analgesic-Antipyretic, Nasal Decongestant, Antihistamine, Nasal Decongestant, Antihistamine, Analgesic-Antipyretic, Nasal Decongestant, Analgesic-Antipyretic, Alpha Adrenergic Agonist, Nasal Decongestant, Antihistamine, Analgesic-Antipyretic
Marketing Division
WARNINGS AND PRECAUTIONS
Montelukast is not indicated for the treatment of acute asthma attacks, including status asthmaticus. Patients should have appropriate short-acting inhaled b-agonist medication available to treat asthma exacerbations. However, therapy with montelukast can be continued during acute asthmatic attacks.
While using montelukast, consult a physician for medical advice if more than the recommended dose of short-acting inhaled bronchodilators is needed.
Patients taking montelukast should not decrease the dose or stop taking any other medicines for asthma unless directed by a physician.
Avoid aspirin or NSAIDs while taking montelukast in patients with known aspirin sensitivity.
Eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy consistent with Churg-Strauss syndrome have been reported rarely in patients with asthma being treated with montelukast.